scholarly journals Gastroenterology Cases of Cutaneous Leukocytoclastic Vasculitis

2013 ◽  
Vol 2013 ◽  
pp. 1-4
Author(s):  
Cumali Karatoprak ◽  
Elif Arabaci ◽  
Kemal Yildiz ◽  
Mustafa Cakirca ◽  
Mehmet Ali Cikrikcioglu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Crohn’S Disease ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Ischemic Colitis ◽  
Bowel Disease ◽  
Leukocytoclastic Vasculitis ◽  
Underlying Disease ◽  
Inflammatory Bowel

Rarely, leukocytoclastic vasculitis can result from ischemic colitis, inflammatory bowel disease, and cryoglobulinemia. There is no established standard for the treatment of leukocytoclastic vasculitis associated with gastroenterologic diseases. This paper presents three cases of leukoytoclastic vasculitis, each of which is associated with a different gastroenterologic condition: ischemic colitis, Crohn’s disease, and chronic hepatitis C. Each condition went into remission by treatment of leukocytoclastic vasculitis, regardless of the underlying disease.

scholarly journals Chronic hepatitis C, inflammatory bowel disease and interferon therapy

2012 ◽  
Vol 6 (5) ◽  
pp. 626-627 ◽  
Author(s):  
Cumali Efe ◽  
Emir Charles Roach ◽  
Tugrul Purnak ◽  
Ersan Ozaslan
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Interferon Therapy ◽  
Inflammatory Bowel

AF.91 TRENDS OF LIVER STIFFNESS IN INFLAMMATORY BOWEL DISEASE WITH CHRONIC HEPATITIS C

2021 ◽  
Vol 53 ◽  
pp. S179
Author(s):  
G. Losurdo ◽  
A. Iannone ◽  
A. Contaldo ◽  
M. Barone ◽  
E. Ierardi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Liver Stiffness ◽  
Inflammatory Bowel

Chronic viral hepatitis and inflammatory bowel disease

2021 ◽  
Vol 11 (2) ◽  
pp. 29-34
Author(s):  
G.V. Volynets ◽  
◽  
A.I. Khavkin ◽  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Immunosuppressive Therapy ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Chronic Viral Hepatitis ◽  
Inflammatory Bowel

The article presents the results of a literature review devoted to the study of the problems of the combined course of inflammatory bowel diseases (IBD), which include ulcerative colitis (UC) and Crohn's disease (CD), and chronic viral hepatitis (CVH) – chronic hepatitis B (CHB) and chronic hepatitis C (CHC). The frequency of occurrence of CHB and CHC in IBD in different countries is presented, which ranges from 1 to 9%. The clinical course of these combined diseases, the possibility of reactivation of hepatitis B virus (HBV) and hepatitis C virus (HCV) during immunosuppressive therapy are described. Recommendations on the specifics of examination and management of patients with combined pathology of IBD and CVH are presented. Conclusion. The combined pathology of IBD and CVH is a significant public health problem around the world that requires further large-scale study. The use of immunosuppressive therapy for IBD can be accompanied by the activation of HBV and HCV infection, therefore, the management of such patients should be individualized. Key words: inflammatory bowel disease, chronic hepatitis B, chronic hepatitis C, immunosuppressive therapy

Addendum to S3-Guidelines Crohn’s disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic – open questions and answers

2020 ◽  
Vol 58 (10) ◽  
pp. 982-1002 ◽  
Author(s):  
Andreas Stallmach ◽  
Andreas Sturm ◽  
Axel Dignass ◽  
Torsten Kucharzik ◽  
Irina Blumenstein ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Bowel Disease ◽  
Underlying Disease ◽  
Specific Patient ◽  
Open Questions ◽  
Questions And Answers ◽  
Inflammatory Bowel

AbstractThe COVID-19 pandemic is a global outbreak of new onset infections with the SARS-CoV-2 virus. To date, more than 3.4 million people have been infected throughout the world. In Germany, approximately 450,000 patients suffer from inflammatory bowel disease; these patients generally require continuous expert care and support. Against the background of a rapidly accumulating knowledge base on SARS-CoV-2, 68 expert authors of the current DGVS guidelines for Crohn’s disease and ulcerative colitis took part in a virtual meeting to compile up-to-date, practice-orientated recommendations aimed at improving the care of patients with IBD. These recommendations address the risk of infection, including the risk for specific patient groups, the possible course of the disease, and consequences for pharmacological and surgical therapies of the underlying disease, as well as general measures for infection prevention and adjuvant prophylactic and therapeutic options.

Localization and Activity of Inflammatory Bowel Disease Using 111ln Leukocyte Imaging

1988 ◽  
Vol 27 (03) ◽  
pp. 83-86 ◽  
Author(s):  
B. Briele ◽  
F. Wolf ◽  
H. J. Biersack ◽  
F. F. Knapp ◽  
A. Hotze
Keyword(s):  
Inflammatory Bowel Disease ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Disease Activity ◽  
Bowel Disease ◽  
Cell Uptake ◽  
Disease Extent ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Leukocyte Imaging

A prospective study was initiated to compare the clinically proven results concerning localization/extent and activity of inflammatory bowel diseases with those of 111ln-oxine leukocyte imaging. All patients studied were completely examined with barium enema x-ray, clinical and laboratory investigations, and endoscopy with histopathology. A total of 31 leukocyte scans were performed in 15 patients (12 with Crohn’s disease, 3 with ulcerative colitis). The scans were graded by comparing the cell uptake of a lesion (when present) and a bone marrow area providing a count ratio (CR). The inflammatory lesions were correctly localized on 26 leukocyte scans, and in 21 scans the scintigraphically estimated extent of disease was identical to endoscopy. In 5 cases the disease extent was underestimated, 4 scans in patients with relapse of Crohn’s disease were falsely negative, and in one patient with remission truly negative. The scintigraphically assessed disease activity was also in a good agreement with clinical disease activity based on histopathology in all cases. We conclude that leukocyte imaging provides valuable information about localization and activity of inflammatory bowel disease.

Sign in / Sign up

Export Citation Format

Share Document